Expression of interleukin-12 is increased in psoriatic skin

被引:191
作者
Yawalkar, N [1 ]
Karlen, S
Hunger, R
Brand, CU
Braathen, LR
机构
[1] Univ Bern, Inselspital, Inst Immunol & Allergol, CH-3010 Bern, Switzerland
[2] Univ Bern, Inselspital, Dermatol Clin, CH-3010 Bern, Switzerland
关键词
interleukin-12; psoriasis; nRT-PCR-immunohistochemistry;
D O I
10.1046/j.1523-1747.1998.00446.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Although the precise underlying pathomechanisms of psoriasis have not been fully elucidated, previous reports suggest that T helper 1-type cytokines are critically involved in the pathogenesis of this disease. Interleukin-12 (IL-12), a heterodimeric cytokine, has been suggested to play a major role in the development of T helper 1 cell responses. In this study, the presence of IL-12 mRNA and protein was investigated in normal human skin as well as nonlesional and lesional psoriatic skin. Messenger RNA levels were determined in biopsy specimens by a standard and a nested reverse transcriptase-polymerase chain reaction method. Additionally, IL-12 protein expression was analyzed in situ by immunohistochemistry using an antibody recognizing IL-12 p70. Whereas specific transcripts for IL-12 p35 were reproducibly detected without any significant differences in all samples, enhanced IL-12 p40 mRNA signals were only found in lesional psoriatic skin as compared with normal and nonlesional psoriatic skin. Furthermore, immunoreactivity for IL-12 p70 was markedly increased in the psoriatic skin lesions and was predominantly expressed on mononuclear cells in the dermis. In conclusion, our data suggest a critical role for IL-12 in promoting and maintaining T cell activation and inducing T helper 1-type cytokines such as interferon-gamma in psoriasis. We speculate that IL-12 might be a key cytokine in the pathogenesis of psoriasis.
引用
收藏
页码:1053 / 1057
页数:5
相关论文
共 32 条
[11]  
Kato T, 1996, J IMMUNOL, V156, P3932
[12]   High level IL-12 production by murine dendritic cells: Upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10 [J].
Koch, F ;
Stanzl, U ;
Jennewein, P ;
Janke, K ;
Heufler, C ;
Kampgen, E ;
Romani, N ;
Schuler, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :741-746
[13]   PSORIASIS INDUCED AT THE INJECTION SITE OF RECOMBINANT INTERFERONS [J].
KOWALZICK, L ;
WEYER, U .
ARCHIVES OF DERMATOLOGY, 1990, 126 (11) :1515-1516
[14]   BACTERIAL SUPERANTIGENS INDUCE T-CELL EXPRESSION OF THE SKIN-SELECTIVE HOMING RECEPTOR, THE CUTANEOUS LYMPHOCYTE-ASSOCIATED ANTIGEN, VIA STIMULATION OF INTERLEUKIN-12 PRODUCTION [J].
LEUNG, DYM ;
GATELY, M ;
TRUMBLE, A ;
FERGUSONDARNELL, B ;
SCHLIEVERT, PM ;
PICKER, LJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (02) :747-753
[15]   RESTRICTED T-CELL RECEPTOR V-BETA GENE USAGE IN THE SKIN OF PATIENTS WITH GUTTATE AND CHRONIC PLAQUE PSORIASIS [J].
LEWIS, HM ;
BAKER, BS ;
BOKTH, S ;
POWLES, AV ;
GARIOCH, JJ ;
VALDIMARSSON, H ;
FRY, L .
BRITISH JOURNAL OF DERMATOLOGY, 1993, 129 (05) :514-520
[16]   INSITU LOCALIZATION OF INTERFERONS IN PSORIATIC LESIONS [J].
LIVDEN, JK ;
NILSEN, R ;
BJERKE, JR ;
MATRE, R .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 1989, 281 (06) :392-397
[17]  
Ma XJ, 1997, CHEM IMMUNOL, V68, P1
[18]  
MENSSEN A, 1995, J IMMUNOL, V155, P4078
[19]   Lymphocyte activation in the pathogenesis of psoriasis [J].
Norris, DA ;
Travers, JB ;
Leung, DYM .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 109 (01) :1-4
[20]  
Presky DH, 1998, J IMMUNOL, V160, P2174